|
Code
|
6161C
|
|
MA number
|
EU/1/17/1233/003
|
|
Product Form:
|
tbl slg 30x2,9 mg/0,71 mg (blis.PVC/OPA/Al/PVC//Al/PET/papier)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
Accord Healthcare S.L.U, Spain
|
|
Therapeutic Class:
|
19 - ANTIDOTA, DETOXICANTIA
|
|
ATC:
|
| N |
NERVOUS SYSTEM |
| N07 |
OTHER NERVOUS SYSTEM DRUGS |
| N07B |
DRUGS USED IN ADDICTIVE DISORDERS |
| N07BC |
Drugs used in opioid dependence |
| N07BC51 |
Buprenorphine, combinations |
|
|
Shelf life:
|
36 |
|
Container:
|
blister OPA/Al/PVC/paper/PE/Al
|
|
Route of admin.:
|
Sublingual use
|
European Medicines Agency's database
